Search research articles
Contact Us
Filters
Showing results (381-390 of 499) with videos related to
Page
of 50
Sort By:
Lancet (London, England)
|
March 25, 2008
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Hepatocellular Carcinoma
|
October 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
Ruth Plummer, Alastair Greystoke, Gregory Naylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial
Josep Tabernero, Rocio Garcia-Carbonero, James Cassidy, et al.
Journal of Gastric Cancer
|
July 7, 2017
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
Charles S Fuchs, Kei Muro, Jiri Tomasek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
The New England Journal of Medicine
|
May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i>-Mutated Colorectal Cancer
Elena Elez, Takayuki Yoshino, Lin Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker, Guillermo Mendez, Joseph Chao, et al.
Endoscopy
|
February 6, 2019
Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline
Cesare Hassan, Piotr Tomasz Wysocki, Lorenzo Fuccio, et al.
Current Medical Research and Opinion
|
July 7, 2021
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study
Hiroya Taniguchi, Takayuki Yoshino, Kensei Yamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, et al.
Page
of 50
Search research articles
Search
Showing results (381-390 of 499) with videos related to
Sort By:
Page
of 50
Lancet (London, England)
|
March 25, 2008
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Hepatocellular Carcinoma
|
October 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
Ruth Plummer, Alastair Greystoke, Gregory Naylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial
Josep Tabernero, Rocio Garcia-Carbonero, James Cassidy, et al.
Journal of Gastric Cancer
|
July 7, 2017
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
Charles S Fuchs, Kei Muro, Jiri Tomasek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
The New England Journal of Medicine
|
May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i>-Mutated Colorectal Cancer
Elena Elez, Takayuki Yoshino, Lin Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker, Guillermo Mendez, Joseph Chao, et al.
Endoscopy
|
February 6, 2019
Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline
Cesare Hassan, Piotr Tomasz Wysocki, Lorenzo Fuccio, et al.
Current Medical Research and Opinion
|
July 7, 2021
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study
Hiroya Taniguchi, Takayuki Yoshino, Kensei Yamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2010
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, et al.
Page
of 50